In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.
In vitro characterization of 6-[18F]fluoro-A-85380, a high-affinity ligand for alpha4beta2* nicotinic acetylcholine receptors.
复制标题
6-[18F]氟-A-85380（α4β2* 烟碱乙酰胆碱受体的高亲和力配体）的体外表征。
DOI：
10.1002/syn.20096
复制
发表时间：
2005
期刊：
影响因子：
--
通讯作者：
London,EdytheD
中科院分区：
文献类型：
--
作者：
Gundisch,Daniela;Koren,AndreiO;Horti,AndrewG;Pavlova,OlgaA;Kimes,AlaneS;Mukhin,AlexeyG;London,EdytheD
Nicotinic acetylcholine receptors are involved in tobacco dependence and several other neuropathologies (e.g., Alzheimer's disease, Parkinson's disease), as well as in attention, learning, and memory. Performing in vivo imaging of these receptors in humans holds great promise for understanding their role in these conditions. Recently, three radiohalogenated analogs of 3‐(2(S)‐azetidinylmethoxy)pyridine (A‐ 85380) were used successfully for the in vivo visualization of α4β2* nicotinic receptors in the human brain with PET/SPECT. Herein, we present the results of the in vitro characterization of one of these radioligands, 6‐[18F]fluoro‐3‐(2(S)‐azetidinylmethoxy)‐pyridine (6‐[18F]fluoro‐A‐85380), which is a fluoro‐analog of the potent nonopioid analgesic ABT‐594. In human postmortem cortical tissue, 6‐[18F]fluoro‐A‐85380 reversibly binds with high affinity to a single population of sites (Kd= 59 pM at 37°C, Bmax= 0.7 pmol/g tissue). The binding is fully reversible and is characterized at 37°C by T1/2assoc= 2.2 min (at a ligand concentration of 39 pM) and by T1/2dissoc= 3.6 min. 6‐Fluoro‐A‐85380 exhibits clear selectivity for α4β2* over the other major mammalian nicotinic receptor subtypes: α7, α3β4, and muscle‐type. These results suggest that 6‐[18F]fluoro‐A‐85380 is a promising radioligand for in vivo imaging of brain α4β2* nicotinic receptors. Synapse 55:89–97, 2005. Published 2004 Wiley‐Liss, Inc.
